Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia

F. Melazzini, F. Palombo, A. Balduini, D. De Rocco, C. Marconi, P. Noris, C. Gnan, T. Pippucci, V. Bozzi, M. Faleschini, S. Barozzi, M. Doubek, CA. Di Buduo, KS. Kozubik, L. Radova, G. Loffredo, S. Pospisilova, C. Alfano, M. Seri, CL. Balduini,...

. 2016 ; 101 (11) : 1333-1342. [pub] 20160630

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023552

Grantová podpora
NV16-29447A MZ0 CEP - Centrální evidence projektů

ETV6-related thrombocytopenia is an autosomal dominant thrombocytopenia that has been recently identified in a few families and has been suspected to predispose to hematologic malignancies. To gain further information on this disorder, we searched for ETV6 mutations in the 130 families with inherited thrombocytopenia of unknown origin from our cohort of 274 consecutive pedigrees with familial thrombocytopenia. We identified 20 patients with ETV6-related thrombocytopenia from seven pedigrees. They have five different ETV6 variants, including three novel mutations affecting the highly conserved E26 transformation-specific domain. The relative frequency of ETV6-related thrombocytopenia was 2.6% in the whole case series and 4.6% among the families with known forms of inherited thrombocytopenia. The degree of thrombocytopenia and bleeding tendency of the patients with ETV6-related thrombocytopenia were mild, but four subjects developed B-cell acute lymphoblastic leukemia during childhood, resulting in a significantly higher incidence of this condition compared to that in the general population. Clinical and laboratory findings did not identify any particular defects that could lead to the suspicion of this disorder from the routine diagnostic workup. However, at variance with most inherited thrombocytopenias, platelets were not enlarged. In vitro studies revealed that the maturation of the patients' megakaryocytes was defective and that the patients have impaired proplatelet formation. Moreover, platelets from patients with ETV6-related thrombocytopenia have reduced ability to spread on fibrinogen. Since the dominant thrombocytopenias due to mutations in RUNX1 and ANKRD26 are also characterized by normal platelet size and predispose to hematologic malignancies, we suggest that screening for ETV6, RUNX1 and ANKRD26 mutations should be performed in all subjects with autosomal dominant thrombocytopenia and normal platelet size.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023552
003      
CZ-PrNML
005      
20170831112030.0
007      
ta
008      
170720s2016 it f 000 0|eng||
009      
AR
024    7_
$a 10.3324/haematol.2016.147496 $2 doi
035    __
$a (PubMed)27365488
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Melazzini, Federica $u Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
245    10
$a Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia / $c F. Melazzini, F. Palombo, A. Balduini, D. De Rocco, C. Marconi, P. Noris, C. Gnan, T. Pippucci, V. Bozzi, M. Faleschini, S. Barozzi, M. Doubek, CA. Di Buduo, KS. Kozubik, L. Radova, G. Loffredo, S. Pospisilova, C. Alfano, M. Seri, CL. Balduini, A. Pecci, A. Savoia,
520    9_
$a ETV6-related thrombocytopenia is an autosomal dominant thrombocytopenia that has been recently identified in a few families and has been suspected to predispose to hematologic malignancies. To gain further information on this disorder, we searched for ETV6 mutations in the 130 families with inherited thrombocytopenia of unknown origin from our cohort of 274 consecutive pedigrees with familial thrombocytopenia. We identified 20 patients with ETV6-related thrombocytopenia from seven pedigrees. They have five different ETV6 variants, including three novel mutations affecting the highly conserved E26 transformation-specific domain. The relative frequency of ETV6-related thrombocytopenia was 2.6% in the whole case series and 4.6% among the families with known forms of inherited thrombocytopenia. The degree of thrombocytopenia and bleeding tendency of the patients with ETV6-related thrombocytopenia were mild, but four subjects developed B-cell acute lymphoblastic leukemia during childhood, resulting in a significantly higher incidence of this condition compared to that in the general population. Clinical and laboratory findings did not identify any particular defects that could lead to the suspicion of this disorder from the routine diagnostic workup. However, at variance with most inherited thrombocytopenias, platelets were not enlarged. In vitro studies revealed that the maturation of the patients' megakaryocytes was defective and that the patients have impaired proplatelet formation. Moreover, platelets from patients with ETV6-related thrombocytopenia have reduced ability to spread on fibrinogen. Since the dominant thrombocytopenias due to mutations in RUNX1 and ANKRD26 are also characterized by normal platelet size and predispose to hematologic malignancies, we suggest that screening for ETV6, RUNX1 and ANKRD26 mutations should be performed in all subjects with autosomal dominant thrombocytopenia and normal platelet size.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a nádorová transformace buněk $x genetika $7 D002471
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a protein PEBP2A2 $x genetika $7 D050676
650    _2
$a rodina $7 D005190
650    _2
$a genetická predispozice k nemoci $x genetika $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    _2
$a rodokmen $7 D010375
650    _2
$a akutní lymfatická leukemie $x etiologie $7 D054198
650    _2
$a protoonkogenní proteiny c-ets $x genetika $7 D050783
650    _2
$a represorové proteiny $x genetika $7 D012097
650    _2
$a trombocytopenie $x genetika $x patologie $7 D013921
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Palombo, Flavia $u Department of Medical and Surgical Science, Policlinico Sant'Orsola Malpighi and University of Bologna, Italy.
700    1_
$a Balduini, Alessandra $u Department of Molecular Medicine, University of Pavia, Italy. Department of Biomedical Engineering, Tufts University, Medford, MA, USA.
700    1_
$a De Rocco, Daniela $u Department of Medical, Surgical and Health Sciences, IRCCS Burlo Garofolo and University of Trieste, Italy.
700    1_
$a Marconi, Caterina $u Department of Medical and Surgical Science, Policlinico Sant'Orsola Malpighi and University of Bologna, Italy.
700    1_
$a Noris, Patrizia $u Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
700    1_
$a Gnan, Chiara $u Department of Medical, Surgical and Health Sciences, IRCCS Burlo Garofolo and University of Trieste, Italy.
700    1_
$a Pippucci, Tommaso $u Department of Medical and Surgical Science, Policlinico Sant'Orsola Malpighi and University of Bologna, Italy.
700    1_
$a Bozzi, Valeria $u Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
700    1_
$a Faleschini, Michela $u Department of Medical, Surgical and Health Sciences, IRCCS Burlo Garofolo and University of Trieste, Italy.
700    1_
$a Barozzi, Serena $u Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
700    1_
$a Doubek, Michael $u University Hospital and Masaryk University, Brno, Czech Republic.
700    1_
$a Di Buduo, Christian A $u Department of Molecular Medicine, University of Pavia, Italy.
700    1_
$a Kozubik, Katerina Stano $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Radova, Lenka $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Loffredo, Giuseppe $u Department of Oncology, Azienda "Santobono-Pausilipon", Pausilipon Hospital, Napoli, Italy.
700    1_
$a Pospisilova, Sarka $u Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Alfano, Caterina $u Maurice Wohl Institute, King's College London, UK. $7 gn_A_00004071
700    1_
$a Seri, Marco $u Department of Medical and Surgical Science, Policlinico Sant'Orsola Malpighi and University of Bologna, Italy.
700    1_
$a Balduini, Carlo L $u Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy.
700    1_
$a Pecci, Alessandro $u Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy alessandro.pecci@unipv.it.
700    1_
$a Savoia, Anna $u Department of Medical, Surgical and Health Sciences, IRCCS Burlo Garofolo and University of Trieste, Italy.
773    0_
$w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 101, č. 11 (2016), s. 1333-1342
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27365488 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170831112620 $b ABA008
999    __
$a ok $b bmc $g 1239233 $s 984465
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 101 $c 11 $d 1333-1342 $e 20160630 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963
GRA    __
$a NV16-29447A $p MZ0
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace